2015
DOI: 10.1007/s13277-015-3198-4
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers and signaling pathways of colorectal cancer stem cells

Abstract: The progression of colorectal cancer is commonly characterized by accumulation of genetic or epigenetic abnormalities, altering regulation of gene expression as well as normal protein structures and functions. Nonetheless, there are some questions that remain to be elucidated, such as the origin of cancer cells and populations of cells initiating and propagating tumor development. Currently, there are two rival theories describing the process of carcinogenesis. One is the stochastic model, arguing that any cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(33 citation statements)
references
References 202 publications
0
30
0
Order By: Relevance
“…Additional markers such as CD24, CD166 (ALCAM), Oct4, Nanog, Sox2, ALDH1, CD166, CD26, EpCAM are reportedly expressed in colon CSC (Abetov et al, 2015, Wahab et al, 2017. Additional markers such as CD24, CD166 (ALCAM), Oct4, Nanog, Sox2, ALDH1, CD166, CD26, EpCAM are reportedly expressed in colon CSC (Abetov et al, 2015, Wahab et al, 2017.…”
Section: Discussionmentioning
confidence: 99%
“…Additional markers such as CD24, CD166 (ALCAM), Oct4, Nanog, Sox2, ALDH1, CD166, CD26, EpCAM are reportedly expressed in colon CSC (Abetov et al, 2015, Wahab et al, 2017. Additional markers such as CD24, CD166 (ALCAM), Oct4, Nanog, Sox2, ALDH1, CD166, CD26, EpCAM are reportedly expressed in colon CSC (Abetov et al, 2015, Wahab et al, 2017.…”
Section: Discussionmentioning
confidence: 99%
“…Identification of new prognostic biomarkers could be a useful tool in predicting disease development and making personalized treatment plans 48. With the help of TCGA data and other approaches, now studies have located numbers of molecules that might be used as biomarkers 114117. Besides the expected biomarkers such as SMAD family member 4, APC, tumor protein p53, phosphatidylinositol- 4,5-bisphosphate 3-kinase catalytic subunit alpha, and KRAS proto-oncogene (KRAS) mutations, frequent mutations in AT-rich interaction domain 1A, sex determining region Y-box 9, and FAM123B/WTX were detected in CRC, indicating that these could be used as specific biomarkers for CRC 116…”
Section: Hh Signaling Pathwaymentioning
confidence: 99%
“…The Wnt/β-catenin signaling pathway is highly conserved in evolution and found in all metazoan animals [37], and it regulates many life activities and processes [3840]. Many cases of dysregulation in the pathway have been shown to promote colon tumorigenesis [41].…”
Section: Discussionmentioning
confidence: 99%